 |
 |
|
|
| |
Company
Name
|
Golden Meditech Company Limited
("Golden Meditech")
|
|
|
Stock Code
|
8180.HK
|
|
| |
Brief History |
Golden Meditech has its origin in the early 1990s when the Group's founder, envisaging the vast potential of the medical device industry in China, began investing in the research and development of Autologous Blood Recovery System ("ABRS").
Established in 2000 to produce the ABRS, the same year when PRC's State Food and Drug Administration ("SFDA") approved the ABRS
|
|
| |
Date of Initial Listing on GEM |
28 December, 2001 |
|
| |
Founder & Chairperson |
Mr KAM Yuen |
|
| |
Name of Directors |
Executive Directors:
- Mr KAM Yuen
- Mr LU Tian Long
- Ms JIN Lu
- Ms ZHENG Ting
Independent Non-executive Directors:
- Mr GAO Zong Ze
- Prof CAO Gang
- Prof GU Qiao |
|
| |
Audit Committee |
Comprises three independent non-executive Directors:
- Prof CAO Gang (Chairman)
- Mr GAO Zong Ze
- Prof GU Qiao |
|
| |
Shareholders |
| 71.89% owned by the public |
|
28.11% owned by Bio Garden (wholly-owned by Mr KAM Yuen; its holding of Golden Meditech's shares remains 433,916,000) |
| (updated as of March 31, 2008) | |
|
| |
Other persons who have over 5% interest |
| Mr Kent C. McCarthy and Jayhawk China Fund (Cayman) Ltd - 19.39% |
|
Martin Currie (Holdings) Ltd. - 7.44% |
| (updated as of March 31, 2008) | |
|
| |
Number of Ordinary Shares in Issue |
1,543,522,000 (updated on 26 Jun 2008) |
|
| |
Par Value of Ordinary Shares in Issue |
HK$0.10 each |
|
| |
Board lot size |
4,000 shares |
|
| |
Business Structure |
100% Jingjing (Medical Device Segment)
50.25% China Stem Cells Holdings (Cord Blood Bank Segment)
40% China Healthcare Inc. (Chinese Herbal Medicine Division)
|
|
| |
Financial Year End Date |
On the 31st of March |
|
| |
Turnover |
FY2007/08: HK$421,147,000
FY2006/07: HK$331,134,000
FY 2005/06: HK$280,578,000
FY 2004/05: HK$238,991,000
FY 2003/04: HK$174,595,000
|
|
| |
Profit Attributable to Equity Holders of the Company |
FY2007/08: HK$683,744,000
FY2006/07: HK$223,365,000
FY 2005/06: HK$563,824,000
FY 2004/05: HK$138,263,000
FY 2003/04: HK$104,431,000
|
|
| |
Revenue Breakdown |
FY 2007/08:
67% from Medical Device Segment
33% from Cord Blood Bank Segment
|
|
| |
Auditors |
KPMG |
|
| |
Legal
Adviser |
Jones Day |
|
| |
Head Office |
| BEIJING Office: |
Room 11, 7/F, Tower E1, Beijing Oriental Plaza, No. 1 East Chang An Ave., Dong Cheng District, Beijing, 100738 China | Telephone number:(86-10) 8518-5515/16
Fax number:(86-10) 8518-6675
| HONG KONG Office: |
48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong | Telephone number:(852) 3605-8180
Fax number:(852) 3605-8181 |
|
| |
Website |
www.goldenmeditech.com |
|
| |
|
|
|
|
|
|
|
|
|
|
|
